![](https://investorshub.advfn.com/uicon/17484.png?cb=1489146554)
Tuesday, March 07, 2017 11:48:10 AM
Just that that product formulation had problems and was abandoned.
You said Viabecline was the same as Diabecline and needed to be licensed by Keough. That actually brings up a question. If Keough owns the patent, why did he need a license to produce Diabecline?
Seems clear that Phillips referred to both Keough and Chris as licensees.
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM